Goodman Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Goodman Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-79,905	Closed	-$5.61M	–	46
2015 Q4	$5.61M	Buy	79,905 +949	+1%	+$64.7K	3.4%	10
2015 Q3	$4.92M	Buy	78,956 +125	+0.2%	+$9.85K	3.13%	12
2015 Q2	$6.63M	Sell	78,831 -4,599	-6%	-$358K	4.15%	3
2015 Q1	$6.27M	Sell	83,430 -27,141	-25%	-$1.9M	3.89%	3
2014 Q4	$6.87M	Sell	110,571 -3,780	-3%	-$215K	4.65%	1
2014 Q3	$5.95M	Sell	114,351 -12,720	-10%	-$649K	4.02%	2
2014 Q2	$6.52M	Sell	127,071 -4,500	-3%	-$203K	3.9%	2
2014 Q1	$6.25M	Sell	131,571 -1,650	-1%	-$84.5K	3.82%	3
2013 Q4	$5.78M	Sell	133,221 -1,080	-0.8%	-$44.7K	3.67%	4
2013 Q3	$5.78M	Buy	134,301 +375	+0.3%	+$15.2K	4.02%	1
2013 Q2	$4.65M	Buy	+133,926	New	+$4.71M	3.52%	5

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Goodman Financial's XBI Position: Q1 2016 in Review

Goodman Financial sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2016, closing a stake of 79,905 shares — an estimated $5.61M sold.

Goodman Financial first reported a position in XBI in Q2 2013 and held it in 11 quarters. The position peaked at $6.87M in Q4 2014. 195 funds tracked by Wall St. Rank hold XBI as of Q1 2016.

Goodman Financial reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2016 after selling out during the quarter.
Goodman Financial sold 79,905 State Street SPDR S&P Biotech ETF shares in Q1 2016, an estimated $5.61M.
Goodman Financial first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 11 quarters.
Goodman Financial's State Street SPDR S&P Biotech ETF position peaked at $6.87M in Q4 2014.
195 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2016.

Based on Goodman Financial's 13F filing for Q1 2016, filed 4 May 2016.